XSTONOSA
Market cap5mUSD
Dec 23, Last price
0.94SEK
1D
2.17%
1Q
57.98%
Jan 2017
-96.03%
IPO
-95.00%
Name
Frisq Holding AB
Chart & Performance
P/E
—
P/S
6.04
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
51.42%
Rev. gr., 5y
14.61%
Revenues
10m
+230.04%
Net income
-47m
L+23.58%
CFO
-17m
L+241.04%
Profile
Nosa Plugs AB, a medical technology company, manufactures and sells intranasal breathing products primarily in Europe and North America. Its products include NOSA plugs, such as NOSA odor control products for odor protection; NOSA microbial control products to reduce the exposure of viruses and bacteria by inhalation through the nose; and NOSA allergy filter that filters harmful airborne particles, such as pollen, pet dander, dust, and mold. The company was incorporated in 2014 and is based in Stockholm, Sweden.
Valuation
Title SEK in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||
Revenues | 10,393 230.04% | 3,149 -46.21% | 5,854 328.24% | |||||
Cost of revenue | 3,609 | 10,474 | 55,762 | |||||
Unusual Expense (Income) | ||||||||
NOPBT | 6,784 | (7,325) | (49,908) | |||||
NOPBT Margin | 65.27% | |||||||
Operating Taxes | 3,686 | (19,962) | ||||||
Tax Rate | ||||||||
NOPAT | 6,784 | (11,011) | (29,946) | |||||
Net income | (46,554) 23.58% | (37,670) -35.68% | (58,565) -74.44% | |||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | 2,313 | 16,721 | (238) | |||||
BB yield | -1.82% | 0.22% | ||||||
| Debt | ||||||||
Debt current | 862 | 650 | 2,867 | |||||
Long-term debt | 2,054 | 1,489 | 15,211 | |||||
Deferred revenue | ||||||||
Other long-term liabilities | (6,172) | |||||||
Net debt | 1,731 | (10,467) | (21,382) | |||||
| Cash flow | ||||||||
Cash from operating activities | (17,499) | (5,131) | (6,208) | |||||
CAPEX | (1,520) | (61) | (10,602) | |||||
Cash from investing activities | 14,552 | (9,381) | (52,200) | |||||
Cash from financing activities | 1,607 | 16,721 | (119) | |||||
FCF | 13,013 | (7,929) | (38,307) | |||||
| Balance | ||||||||
Cash | 1,185 | 12,606 | 10,397 | |||||
Long term investments | 29,063 | |||||||
Excess cash | 665 | 12,449 | 39,167 | |||||
Stockholders' equity | (82,924) | (489,085) | (452,531) | |||||
Invested Capital | 111,551 | 508,008 | 494,454 | |||||
ROIC | 2.19% | |||||||
ROCE | 23.70% | |||||||
| EV | ||||||||
Common stock shares outstanding | 159,848 | 61,955 | 48,024 | |||||
Price | 0.79 | 2.28 -40.11% | ||||||
Market cap | 126,759 | 109,303 -9.39% | ||||||
EV | 128,490 | 87,921 | ||||||
EBITDA | 8,269 | (1,175) | (29,946) | |||||
EV/EBITDA | 15.54 | |||||||
Interest | 92 | 303 | ||||||
Interest/NOPBT | 1.36% | |||||||